[go: up one dir, main page]

Vonder Helm et al., 1994 - Google Patents

[7] Identification, purification, and cell culture assays of retroviral proteases

Vonder Helm et al., 1994

Document ID
15766133207493713024
Author
Vonder Helm K
Seelmeier S
Kisselev A
Nitschko H
Publication year
Publication venue
Methods in enzymology

External Links

Snippet

Publisher Summary This chapter focuses on identification, purification, and cell culture assays of retroviral proteases. The retroviral protease is activated by autocatalytic processing from the zymogen-type gag-pol precursor. The mature protease then processes …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse Transcribing RNA Viruses
    • C12N2740/00011—Reverse Transcribing RNA Viruses
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Similar Documents

Publication Publication Date Title
Pettit et al. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions
Kräusslich et al. Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli
Loeb et al. Mutational analysis of human immunodeficiency virus type 1 protease suggests functional homology with aspartic proteinases
Kräusslich et al. Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides.
US5627043A (en) Yeast strains used to identify inhibitors of dibasic amino acid processing endoproteases
Vogt Proteolytic processing and particle maturation
Seelmeier et al. Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.
Wang et al. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant
Stewart et al. Properties of avian retrovirus particles defective in viral protease
Partin et al. Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase
Jacobs et al. The HIV-1 Gag precursor Pr55gag synthesized in yeast is myristoylated and targeted to the plasma membrane
Cheng et al. High-level synthesis of recombinant HIV-1 protease and the recovery of active enzyme from inclusion bodies
CA2059541C (en) Method of preparing a plasmid having both the ability to express a retroviral gene and the ability to process expression products after translation, the resultant plasmid and expression products thereof
Ott et al. Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant
Wondrak et al. The gag precursor contains a specific HIV‐1 protease cleavage site between the NC (P7) and P1 proteins
Roberts et al. In situ processing of a retroviral nucleocapsid protein by the viral proteinase
Menéndez-Arias et al. Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme
Vonder Helm et al. [7] Identification, purification, and cell culture assays of retroviral proteases
Gaedigk-Nitschko et al. Cleavage of recombinant and cell derived human immunodeficiency virus 1 (HIV-1) Nef protein by HIV-1 protease
Luban et al. Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria
Almog et al. A p6Pol-protease fusion protein is present in mature particles of human immunodeficiency virus type 1
WO1990000556A1 (en) Synthetic hiv protease gene and method for its expression
Stebbins et al. [1] Expression systems for retroviral proteases
Yovandich et al. Alteration of zinc-binding residues of simian immunodeficiency virus p8NC results in subtle differences in Gag processing and virion maturation associated with degradative loss of mutant NC
Cordelier et al. Mechanisms of α1-antitrypsin inhibition of cellular serine proteases and HIV-1 protease that are essential for HIV-1 morphogenesis